Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. GH Research PLC
  6. Summary
    GHRS   IE000GID8VI0

GH RESEARCH PLC

(GHRS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
23.21(c) 23.31(c) 23.34(c) 20.7(c) 21.14(c) Last
7 945 3 449 7 529 54 182 71 776 Volume
+0.04% +0.43% +0.13% -11.31% +2.13% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -24,9 M - -
Net cash position 2021 274 M - -
P/E ratio 2021 -38,9x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -58,2 M - -
Net cash position 2022 427 M - -
P/E ratio 2022 -20,9x
Yield 2022 -
Capitalization 1 068 M 1 068 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 8
Free-Float 57,5%
More Financials
Company
GH Research PLC is a clinical-stage biopharmaceutical company. The Company is engaged in offering treatment for psychiatric and neurological disorders. It focuses on developing its 5-Methoxy-N, N-Dimethyltryptamine (5-MeO-DMT), therapies for the treatment of patients with Treatment-Resistant Depression (TRD). Its portfolio includes GH001, its inhalable 5-MeO-DMT product candidate which is delivered via a... 
More about the company
All news about GH RESEARCH PLC
07/20GH RESEARCH : Cowen Starts GH Research at Outperform
MT
07/20GH RESEARCH : JMP Securities Starts GH Research at Market Outperform With $35 Pr..
MT
07/20GH RESEARCH : Stifel Starts GH Research at Buy With $26 Price Target
MT
07/20GH RESEARCH : Canaccord Genuity Initiates Coverage on GH Research With Buy Ratin..
MT
06/25UPDATE : Drugmaker GH Research Surges on Nasdaq Debut
MT
06/25GH RESEARCH : Prices IPO
MT
06/24GH Research PLC has completed an IPO in the amount of $160 million.
CI
06/04GH Research PLC has filed an IPO in the amount of $100 million.
CI
More news
News in other languages on GH RESEARCH PLC

- No features available -

More news
Analyst Recommendations on GH RESEARCH PLC
More recommendations
Chart GH RESEARCH PLC
Duration : Period :
GH Research PLC Technical Analysis Chart | GHRS | IE000GID8VI0 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 21,14 $
Average target price 32,00 $
Spread / Average Target 51,4%
EPS Revisions
Managers and Directors
Theis Terwey Chief Executive Officer
Julie Ryan Group Finance Director
Florian Schönharting Non-Executive Chairman
Spike N. Loy Non-Executive Director
Michael Forer Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
GH RESEARCH PLC0.00%1 068
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420